These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 34752370)
21. Correlation study on 18F-FDG PET/CT metabolic characteristics of primary lesion with clinical stage in lung cancer. Hu WD; Wang HC; Wang YB; Cui LL; Chen XH Q J Nucl Med Mol Imaging; 2021 Jun; 65(2):172-177. PubMed ID: 30916535 [TBL] [Abstract][Full Text] [Related]
22. Pretreatment quantitative Gencturk M; Ozturk K; Koksel Y; Li F; Cayci Z Clin Imaging; 2019; 53():17-24. PubMed ID: 30308429 [TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of preoperative metabolic tumour volume and total lesion glycolysis measured by (18)F-FDG PET/CT in squamous cell carcinoma of the oral cavity. Ryu IS; Kim JS; Roh JL; Cho KJ; Choi SH; Nam SY; Kim SY Eur J Nucl Med Mol Imaging; 2014 Mar; 41(3):452-61. PubMed ID: 24081448 [TBL] [Abstract][Full Text] [Related]
24. Usefulness of Li Y; Li Y; Huang Y; Wu X; Yang Z; Wu C; Jiang L Ann Nucl Med; 2021 Sep; 35(9):1048-1057. PubMed ID: 34101153 [TBL] [Abstract][Full Text] [Related]
25. [The relationship between (18)F-FDG PET/CT metabolic parameters and clinicopathological features of breast cancer]. Tang B; Zhang Y; Zhou J; Xu Y; Li TR; Ding CY Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):280-285. PubMed ID: 28550668 [No Abstract] [Full Text] [Related]
26. Prognostic Value of the Sum of Metabolic Tumor Volume of Primary Tumor and Lymph Nodes Using 18F-FDG PET/CT in Patients With Cervical Cancer. Hong JH; Min KJ; Lee JK; So KA; Jung US; Kim S; Eo JS Medicine (Baltimore); 2016 Mar; 95(9):e2992. PubMed ID: 26945420 [TBL] [Abstract][Full Text] [Related]
27. Prognostic Value of Volumetric Parameters Measured by Pretreatment 18F FDG PET/CT in Patients With Cutaneous Malignant Melanoma. Son SH; Kang SM; Jeong SY; Lee SW; Lee SJ; Lee J; Ahn BC Clin Nucl Med; 2016 Jun; 41(6):e266-73. PubMed ID: 27055144 [TBL] [Abstract][Full Text] [Related]
28. Use of Rudžianskas V; Korobeinikova E; Rudžianskienė M; Jaselskė E; Adlienė D; Šedienė S; Kulakienė I; Padervinskis E; Jurkienė N; Juozaitytė E Medicina (Kaunas); 2018 Dec; 54(6):. PubMed ID: 30544718 [No Abstract] [Full Text] [Related]
29. Evaluation of the prognostic value of different methods of calculating the tumour metabolic volume with Guzmán Ortiz S; Mucientes Rasilla J; Vargas Núñez JA; Royuela A; Navarro Matilla B; Mitjavila Casanovas M Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(6):340-346. PubMed ID: 32646783 [TBL] [Abstract][Full Text] [Related]
30. Mantziari S; Pomoni A; Prior JO; Winiker M; Allemann P; Demartines N; Schäfer M BMC Med Imaging; 2020 Jan; 20(1):7. PubMed ID: 31969127 [TBL] [Abstract][Full Text] [Related]
31. Prognostic value of FDG PET metabolic tumor volume in human papillomavirus-positive stage III and IV oropharyngeal squamous cell carcinoma. Alluri KC; Tahari AK; Wahl RL; Koch W; Chung CH; Subramaniam RM AJR Am J Roentgenol; 2014 Oct; 203(4):897-903. PubMed ID: 25247958 [TBL] [Abstract][Full Text] [Related]
33. Prognostic value of metabolic parameters determined by preoperative ¹⁸F-FDG PET/CT in patients with uterine carcinosarcoma. Lee HJ; Lee JJ; Park JY; Kim JH; Kim YM; Kim YT; Nam JH J Gynecol Oncol; 2017 Jul; 28(4):e43. PubMed ID: 28541634 [TBL] [Abstract][Full Text] [Related]
34. Prognostic value of whole-body total lesion glycolysis at pretreatment FDG PET/CT in non-small cell lung cancer. Chen HH; Chiu NT; Su WC; Guo HR; Lee BF Radiology; 2012 Aug; 264(2):559-66. PubMed ID: 22692034 [TBL] [Abstract][Full Text] [Related]
35. Prognostic value of baseline Xia L; Li X; Zhu J; Gao Z; Zhang J; Yang G; Wang Z Radiat Oncol; 2023 Feb; 18(1):41. PubMed ID: 36829219 [TBL] [Abstract][Full Text] [Related]
36. Prognostic value of metabolic tumour volume and total lesion glycolysis in Jiménez-Ballvé A; García García-Esquinas M; Salsidua-Arroyo O; Serrano-Palacio A; García-Sáenz JA; Ortega Candil A; Fuentes Ferrer ME; Rodríguez Rey C; Román-Santamaría JM; Moreno F; Carreras-Delgado JL Rev Esp Med Nucl Imagen Mol; 2016; 35(6):365-372. PubMed ID: 26948652 [TBL] [Abstract][Full Text] [Related]
37. The Association of Tumor Burden by 18F-FDG PET/CT and Survival in Vulvar Carcinoma. Mokoala KMG; Lawal IO; Lengana T; Popoola GO; Boshomane TMG; Mokgoro NP; Vorster M; Sathekge MM Clin Nucl Med; 2021 May; 46(5):375-381. PubMed ID: 33630802 [TBL] [Abstract][Full Text] [Related]
38. Value of Intratumoral Metabolic Heterogeneity and Quantitative Pinho DF; King B; Xi Y; Albuquerque K; Lea J; Subramaniam RM AJR Am J Roentgenol; 2020 Apr; 214(4):908-916. PubMed ID: 32069078 [No Abstract] [Full Text] [Related]
39. Prognostic value of volume-based (18)F-fluorodeoxyglucose PET/CT parameters in patients with clinically node-negative oral tongue squamous cell carcinoma. Lee SJ; Choi JY; Lee HJ; Baek CH; Son YI; Hyun SH; Moon SH; Kim BT Korean J Radiol; 2012; 13(6):752-9. PubMed ID: 23118574 [TBL] [Abstract][Full Text] [Related]
40. Metabolic tumor volume and total lesion glycolysis predict tumor progression and survival after salvage surgery for recurrent oral cavity squamous cell carcinoma. Choi WR; Oh JS; Roh JL; Kim JS; Oh I; Choi SH; Nam SY; Kim SY Head Neck; 2019 Jun; 41(6):1846-1853. PubMed ID: 30675738 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]